Track primary indication Status post-infusion for patient care and reporting.
Auto-generated summary of the primary indication displays Treatments and Procedures as well as Status information (First Remission, Second Remission, Relapse, etc.)
Monitor and manage the unique toxicities associated with CAR-T therapy.
Streamlined methodology for capturing and summarizing Assessment and Treatment data for adverse events, including Cytokine Release Syndrome (CRS) and Neurotoxicity.
Evaluate the persistence of CAR-T cells post-infusion.
Track the evaluation method (Molecular Assay, Flow Cytometry, Immunohistochemistry, Other), cell source, and infused cell detection over time.